New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - ciclosporin 100 mg/ml - oral solution - 100 mg/ml - active: ciclosporin 100 mg/ml excipient: hydrogenated castor oil propylene glycol sorbitan oleate

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciclosporin 100 mg/ml - oral solution - 100 mg/ml - active: ciclosporin 100 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - ciclosporin, quantity: 100 mg - capsule, soft - excipient ingredients: polysorbate 20; gelatin; purified water; ethyl lactate; glycerol; sorbitan oleate; titanium dioxide; tricaprin; lecithin; peg-40 hydrogenated castor oil; iron oxide black - ciclosporin is indicated: ? as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. ? for induction and/or maintenance of remission in the nephrotic syndrome. ciclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see section 4.4 special warnings and precautions for use). ? for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. ? in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with quality of life. ? for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.,careful monitoring of all ciclosporin-treated patients is mandatory. ciclosporin should only be used by medical practitioners who are experienced in the use of immunosuppressive therapy (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ciclosporin, quantity: 100 mg - capsule, soft - excipient ingredients: sorbitan oleate; gelatin; purified water; glycerol; titanium dioxide; lecithin; tricaprin; iron oxide black; polysorbate 20; ethyl lactate; peg-40 hydrogenated castor oil - ciclosporin is indicated: ? as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. ? for induction and/or maintenance of remission in the nephrotic syndrome. ciclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see section 4.4 special warnings and precautions for use). ? for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. ? in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with quality of life. ? for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.,careful monitoring of all ciclosporin-treated patients is mandatory. ciclosporin should only be used by medical practitioners who are experienced in the use of immunosuppressive therapy (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ciclosporin, quantity: 100 mg - capsule, soft - excipient ingredients: titanium dioxide; peg-40 hydrogenated castor oil; gelatin; ethyl lactate; sorbitan oleate; polysorbate 20; purified water; lecithin; iron oxide black; tricaprin; glycerol - ciclosporin is indicated: ? as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. ? for induction and/or maintenance of remission in the nephrotic syndrome. ciclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see section 4.4 special warnings and precautions for use). ? for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. ? in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with quality of life. ? for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.,careful monitoring of all ciclosporin-treated patients is mandatory. ciclosporin should only be used by medical practitioners who are experienced in the use of immunosuppressive therapy (see section 4.4 special warnings and precautions for use).

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة المتحدة لصناعة الأدوية - united pharmaceutical manufacturing co. ltd. - ciclosporin 100 mg/ml - 100 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

hexal new zealand pty limited (ceased trading 31.12.2006) - ciclosporin 100mg - soft gelatin capsule - 100 mg - active: ciclosporin 100mg excipient: ethanol glycerol iron oxide red macrogol 400 polyethylene glycol hydrogenated castor oil purified water sorbitol succinylated gelatin tocofersolan

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - ciclosporin 100mg - capsule - 100 mg - active: ciclosporin 100mg excipient: ethanol gelatin     indigo carmine macrogol 3350 macrogol glycerol ricinoleate polysorbate 80 propylene glycol sorbitan oleate

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciclosporin 100mg - capsule - 100 mg - active: ciclosporin 100mg excipient: gelatin

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الأدوية الأردني - the jordan drugstore co - ciclosporin 100 mg - 100 mg